Mr Narendra Modiji
Honourable Prime minister of INDIA
I am a cardiologist in Hubli (Karnataka). I want to thank you for reducing the price of coronary stents. but I want to bring to your kind notice the dynamics in the Indian market and how it is harming Indian poor patients.
Most of the stents imported from abroad were expensive and their price reduction is beneficial to our patients. At the same time, stents produced in India were cheaper, price hike happening from this new rule is harmful to our poor patients.
Prior to the new rule, although MRP written on Indian coronary stents was very high, they were available to the hospitals at 10000 to 18000 INR, depending upon the bulk of purchase. Most cardiologists were treating poor patients with total angioplasty package at 65000 to 70000 INR (BPL and APL card holders).
By this new rule, all the stents including Indian stents even those which cost less than 18000 to the hospitals have become expensive to hospitals i.e. more than 23000 INR.
In fact, I was wishing that new rule will reduce the cost of Indian stents even further, but to the contrary, it has hiked the price.
Please look into this matter on priority as it affecting our poor patients.